APR 02, 2012 08:00 AM PDT

D-dimer in the Management of Venous Thromboembolism

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
    Biography
      Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General's task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master's degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.

    Abstract:

    Venous thromboembolism (VTE) is a serious prothrombotic disease state caused by acquired or inherited factors and is responsible for a high rate of morbidity and mortality.  Deep venous thrombosis (DVT) and pulmonary embolism (PE) refer to VTE located in the deep veins or lungs, respectively.  Diagnostic strategies for identification of VTE, DVT, and PE include imaging as well as laboratory testing methodologies such as the D-dimer assay.  The purpose of this educational activity is to review clinical decision rules, case studies, and the role of the D-dimer assay in the diagnostic management of VTE.

    • Recognize venous thromboembolism: deep-vein thrombosis and pulmonary embolism and its consequences.
    • Discuss the use of D-dimer in the exclusion of patients with clinically suspected first-episode or recurrent deep-vein thrombosis.
    • Discuss the utility of D-dimer in the determination of length of anticoagulation after first-episode deep-vein thrombosis.

    Show Resources
    You May Also Like
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    MAY 02, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 02, 2018 08:00 AM PDT
    Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    Loading Comments...